LivingGLP1
Study S002453

Evaluation of Endoscopic Sleeve Gastroplasty (ESG) as an Alternative Weight Loss Strategy for Patients With Obesity Discontinuing GLP-1 Receptor Agonists Due to Intolerance or Ineffectiveness: A Retrospective Study

Registration

Registration
NCT07190794
Study type
OBSERVATIONAL
Status
TERMINATED
Enrollment
18
Start
2025-12-17
Primary completion
2026-05-26
Lead sponsor
Boston Scientific Corporation
Conditions
Obesity
Interventions
DEVICE:OverStitch™ or OverStitch NXT™; BEHAVIORAL:Lifestyle Modification
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Percent total body weight loss (TBWL) at 1 year from baseline [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.